Mr. Malone is a 2nd generation financial advisor with over 40 years of family experience in wealth management. This combined with his deep entrepreneurial background he launched Malone Wealth in 2021.

The pharmaceutical industry's next billion-dollar blockbuster won't come from a lab alone—it will come from listening to ...

In a powerful keynote, Dr. Namrata Singh, Founder & CEO of Turacoz Group, set a bold tone: "We are at the forefront of a ...

Roche’s drug production operations are set to benefit from the company’s updated U.S. strategy, including with “expanded and ...

The field of tissue engineering and regeneration encompasses a range of technologies, including biomaterials, stem cell therapy, gene therapy, and 3D printing, among others. The major driving factors ...

Scale-up is a common problem encountered in all forms of development across industries, and oral solid dose manufacturing ...

Despite weak financials, Redwire projects strong YoY growth in revenue, EBITDA margin and FCF, outpacing industry averages.

On the research front last week, China-based biotech Remegen released positive Phase III results for its telitacicept in ...

We recently published a list of the 10 Innovative Healthcare Stocks to Watch in 2025. In this article, we are going to take a ...

Denise Bronner, Ph.D., makes the case for and against acquisitions for rejuvenating Big Pharma pipelines. She explains why ...

During a recent panel discussion sponsored by Purdue University, industry leaders explain how the technology is revolutionizing drug development and production ...